Health 2.0 San Francisco: Musings
The Good (1.2) - Momentum, enthusiasm, ideas, capital commitments, execution, analytics, pharmacogenomics and steps in the right direction. Many companies, many voices, many singing the same tune.
The Bad (1) - Cereal aisle effect - clarity or confusion? I almost needed an "organic aisle" of companies focused on patients. As a patient, am I now expected to log into 14 different "portals" to pick up my medication used in my self injectable? But that's what the vendors will tell you. I see, I see . . . I see a bubble. M&A artists rejoice! Need a "Sustainability Prize" next year.
The Ugly (0.0) - Standards (lack of), interoperability, FDA pipeline, massive fragmentation, naivety of some tech entrepreneurs new to healthcare and design centric patient engagement models. Why is the physician seen as a non-entity - he is the primary influencer in most healthcare related decisions - chronic or acute. And why isn't anyone following the money - its a capital economy - insurance companies, PBM's and adjudication companies need to be involved - as much as they are seen as our red haired brother.
Notice I am not on Health 2.0 yet. We think we are - but we are not. We will be when 1 hospital can share the information with another and keep you in the loop - electronically by sending you an email (just like when you transfer money from one account to the other). We will be when you can share your medical device information on the go easily with your physicians and derive actionable adjustments to your regimen from a live person. We will be 2.0 when you are able to influence the market and change how research is conducted.We will be when your social interactions become as important as your clinic interactions. We will be when you are in the drivers seat making a true difference in creating best practices.
But today - you are merely chasing several chickens who fell out of a truck - some with their heads cut off.
0 Comments:
Post a Comment
<< Home